Insider Buying: Medical Developments International (ASX:MVP) Insider Acquires A$28,240.00 in Stock

Medical Developments International Limited (ASX:MVPGet Free Report) insider Russell Basser bought 40,000 shares of the firm’s stock in a transaction dated Thursday, October 30th. The shares were acquired at an average price of A$0.71 per share, for a total transaction of A$28,240.00.

Medical Developments International Stock Performance

The company has a debt-to-equity ratio of 5.00, a current ratio of 2.74 and a quick ratio of 2.54. The stock has a market cap of $98.01 million, a price-to-earnings ratio of -1.88 and a beta of 1.63.

Medical Developments International Company Profile

(Get Free Report)

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices.

Further Reading

Receive News & Ratings for Medical Developments International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Developments International and related companies with MarketBeat.com's FREE daily email newsletter.